DSM Nutritional Products AG and its affiliated companies (hereinafter “DSM”) makes no representations or warranties, either express or implied, of merchantability, fitness for a particular purpose or of any other nature with respect to information or the products to which the information refers. Koninklijke DSM N.V. (Royal DSM, commonly known as DSM Dutch State Mines), is a Dutch multinational corporation active in the fields of health, nutrition and materials. JLL Partners , a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which will be... | November 19, 2013 Summary Royal DSM N.V. (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. Yes, I would like to receive the Pharma Solutions newsletter and related content from DSM. We draw on our unique skills in chemical synthesis and biotechnology to ensure all products meet strict sustainability standards. Innovation is the engine that gets us there by bringing exciting new science-based solutions to market that benefit people, planet, and profit. DSM will use the information you provide for an email newsletter and for general marketing purposes. Together, we innovate in novel therapeutic areas - so you stay at the forefront of the industry. It operates through three segments: Nutrition, Materials, and Innovation Center. At DSM, we aim to help keep the world’s growing population healthy and to improve patients’ quality of life. NEW YORK, NY, USA & HEERLEN, The Netherlands I November 19, 2013 I JLL Partners (“JLL”), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which will be a leading global contract development and … DSM Pharmaceutical Solutions. Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. Details of Royal Dsm's European GMP Inspections. Home >> . For nutrition we’re especially focused on: Nutritional ingredients for the food and beverage, dietary supplement, early life nutrition, medical nutrition and nutrition improvement industries. The report by Orbis Pharma Reports outlines crucial attributes of the global District Heating and Cooling market with detailed understanding of major innovations and events, also highlighting growth plot chalked by leading players 2. Our whitepapers summarize the latest reseach developments, covering key topics in the industry. Leave this field empty if you're human: Stay With Us. Dutch food and chemicals group DSM will spin off its pharmaceuticals unit into a new joint venture majority-owned by private equity firm JLL Partners as the company shifts its focus toward... | … Royal DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. Royal DSM & JLL Create Leading Pharma Services Company in $ 2.6-Billion Transaction LL Partners and Royal DSM recently announced the creation of a new company, which will be a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry with anticipated sales of around $2 billion. DSM has proven success in quality assurance and sustainable practices to deliver only products of the highest standards to our customers. With extensive experience in vitamin APIs and EPA and DHA API intermediates, DSM is in a unique position to provide customers with customized support throughout every stage of product creation and launch. for all DSM's offices and sites. We enable better food for everyone with specialty enzymes, cultures, probiotics, bio-preservation, sugar reduction and savory taste solutions for the food & beverage industry. Explore Vitamins . NEW YORK and HEERLEN, Netherlands, Nov. 19, 2013 /PRNewswire/ -- JLL Partners , a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company,... | November 19, 2013 Global CDMO company combines DSM Pharmaceutical Products and Patheon. With dedicated and regularly audited global facilities, and a growing network of GMP qualified sites, we ensure our products remain consistently high quality. DSM completes acquisition of Human Milk Oligosaccharides supplier, Glycom EP News Bureau Apr 3, 2020. Under the new structure Patheon's owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the … Explore Lipids. Royal DSM N.V. (DSM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. The global Location Finder contains the contact details (address, phone etc.) DSM’s purpose is to create brighter lives for all. Here at DSM we’ve been producing vitamin Active Pharmaceutical Ingredients (APIs) for more than 70 years. This website uses cookies. Royal DSM Positioning Value adding product manufacturers. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. As a global leader in vitamin and lipid manufacturing, DSM leverages its active pharmaceutical ingredient (API) offerings as proven, safe, and innovative agents for life-changing therapies. The protective role of intravenous ascorbic acid (vitamin C) in critically ill patients with Covid-19, DSM’s unique VITALITY survey: How do healthcare professionals perceive value-added medicines with vitamin APIs, New ESPEN Expert Guidelines: Practical Guidance for Nutritional Management in COVID-19 Patients, Explore our broad portfolio of Vitamin APIs, Lipid API intermediates and Novel APIs, Our whitepapers summarize the latest research developments, covering key topics in the industry. Contact us. Royal DSM and JLL create leading pharma services company in $2.6 bn transaction. Long-Chain N-3 Fatty Acids and Cancer Risk: What's the Prognosis? Royal DSM Target Market Human and animal nutrition and health, personal care, pharmaceuticals and automotive. Royal DSM SWOT Analysis Royal DSM Strengths Below are the Strengths in the SWOT Analysis of Royal DSM: 1. Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. Here at DSM we’ve been producing vitamin Active Pharmaceutical Ingredients (APIs) for more than 70 years. Royal DSM has reached a deal to spin off its pharmaceutical business and merge it with contract development and manufacturing organisation (CDMO) Patheon to create a $2.6bn outsourcing giant. This website does not constitute a recommendation or guidance for decisions concerning the purchase, use or application of products and does not relieve the user of the product of the obligation to undertake its own suitability, performance, quality testing or country specific regulatory approvals. We also use website traffic to establish the success of our marketing campaigns. 1. ACTIVE PHARMACEUTICAL INGREDIENTS. JLL Partners (“JLL”), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, … DSM Pharma Solutions Pharmaceuticals Heerlen, Limburg ... Royal DSM is a global purpose-led, science-based company specializing in Nutrition, Health & Sustainable Living. Our broad range of APIs includes vitamins and EPA and DHA intermediates. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. The Dutch supplier announced the job cuts today, explaining that the move will save it €125m to €150m ($144m to $173m) over the next two years. All trademarks, product names, symbols and graphics appearing on this website are the property of DSM. DSM Hydrocolloids is a leading global supplier of gellan gum, xanthan gum, welan gum and pectin to the food and beverage, personal care, home care and other specialty industrial applications. Royal DSM is to spin off its pharmaceuticals business in a deal that will create a US$2.6bn drugmaking business. We’re more than a partner. DSM’s purpose is to create brighter lives for all. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. JLL Partners , a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company,... | December 16, 2020 We see therapies that safely and efficiently help to improve people's lives. High customer … The Dutch material sciences and life sciences company Royal DSM said on Tuesday that it wouldspin off its pharmaceutical manufacturing business into a $2.6 billion joint venture with the New York private equity firm JLL Partners. Find the latest DSM KON (DSM.AS) stock quote, history, news and other vital information to help you with your stock trading and investing. With more than 400 R&D experts, we have the clinical trial knowledge to meet your needs. pharma; contact; Improving patients’ quality of life. I agree with the User Terms and Conditions which can be found here (mandatory). Calorie-free sweetness, inspired by nature, Painting a brighter future with Decovery®. Stay up-to-date on the latest science, events and market trends, Request samples, place orders and view product documentation, Download the latest copy of our Solutions Catalogue. Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. Our commitment to quality, innovation, and sustainable supply make us your reliable, end-to-end, innovative, purpose-led partner to address emerging therapeutic areas benefiting global patient health while helping our customers achieve long-term growth. Next up we have global science based company Royal DSM who will propose in May’s AGM the appointment of Dimitri de Vreeze to the Managing Board. It takes a partner. Innovation is the engine that gets us there by bringing exciting new science-based solutions to market that benefit people, planet, and profit. Global CDMO company combines DSM Pharmaceutical Products and Patheon. Our strong track record with regulatory authorities means you can meet the highest quality standards for all your production and operations - whenever you are located. This takes more than active pharmaceutical ingredients. There is significant interest in HMO use as a dietary supplement and potentially in food and beverage and pet food applications,… SIGNUP FREE NEWSLETTER. In a $2.6 billion deal, Patheon merged with the pharmaceutical division of Royal DSM NV in 2014 after JLL Partners bought a controlling stake in the latter as well, adding significantly to Patheon's European production capacity. The company delivers business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. Please let us know below if you 'opt in' for this newsletter. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company … This site uses cookies to optimize your user experience. Royal DSM. Discover significant research that impacts the market, including emerging therapeutic benefits for vitamin APIs and pharmaceutical lipids - as well as wider industry updates and events. Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living. At DSM, we deliver passion, innovation, and scientific expertise for every stage of your product's life cycle. Royal DSM NV (DSM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. Nutrition, performance materials, polymer intermediates, pharma, and innovation center. Heerlen, NL, 19 Nov 2013 06:10 CET. The Dutch company Royal DSM said it would spin off its pharmaceutical manufacturing business into a $2.6 billion joint venture a private equity firm. The latest in vitamin and lipid research and industry developments, Academic studies and the latest science in educational modules, Videos exploring the growing role of vitamin APIs and lipid API intermediates, Claims and content on this site are intended for North America. Patheon has merged with Royal DSM's pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world's second biggest CMO. We begin our weekly pharma job round-up with news that one of the big boys, AstraZeneca , has appointed Marc Dunoyer to the role of Executive Vice President, Global Portfolio & Product Strategy. At DSM, we aim to help keep the world’s growing population healthy and to improve patients’ quality of life. Royal DSM NV (DSM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon. The company operates in the following segments: Nutrition, Pharma, Performance Materials, Polymer Intermediates, Innovation Center, and Corporate Activities. Explore our reliable broad offering of products, customized solutions and expert services below. Select One partner, multiple APIs. Products with Purpose: New DSM Brand Strategy Marks Transition to End-to-End Pharmaceutical Partner, Supporting customers beyond industry standards – the DSM way, Emerging roles of lipids in the modulation of cancer risk and therapy, DSM Brings New Innovative Therapeutic Concepts to CPhI 2017, DSM speaks at Nicholas Hall OTC Conference, New milestone plant certification in Colombia expands Pharma premix opportunities, DSM obtains Drug Master File number for Vitamin B in China, To Your Health: The Growing Importance of Clinically Relevant Drug-Nutrient Interactions, Back to Basics: The Impact of B-Vitamins on Low Back Pain, The Role of Riboflavin in Resistant Hypertension: A Novel Approach to Treating and Managing High Blood Pressure. The move comes days after the Dutch company announced that it is seeking to streamline its portfolio and has set aside about €3 billion to expand its nutrition business. View all Active Pharmaceutical Ingredients (API) with USDMF manufactured or supplied by Royal DSM on PharmaCompass.com. The Dutch firm will sell the business to private equity firm JLL Partners, which will form the new company by combining DSM Pharmaceutical Products with Patheon, the drug manufacturer in which it is majority shareholder. Headquartered in Heerlen, at the end of 2017 DSM employed 21,054 people in approximately 50 countries and posted net sales of €8.632 billion. We offer both US Drug Master Files (US DMFs) and Certificates of Suitability (CEPs) for all 13 vitamins. Our sustainable supply of high-quality APIs - together with unique expertise in agile innovation and broad ability to manage the market entry registration process - makes us an ideal partner for the development of over-the-counter products and prescription medications. Our products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. You consent to our cookies if you continue to use our website. Royal DSM is a science-based company engaged in nutrition, health, and sustainable living. Previous Next Pause Play. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. At DSM we feel so strongly about doing well by doing good that our company strategy is aligned with the UN’s Sustainable Development Goals (SDGs). Royal DSM has reached a deal to spin off its pharmaceutical business and merge it with contract development and manufacturing organisation (CDMO) Patheon to create a $2.6bn outsourcing giant. Nutrition • Health • Sustainable living. We’re a competitive edge. Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. We are also the global leader in the production of omega-3 fatty acids, including EPA and DHA derived from both sustainable marine sources and microbial fermentation. DSM will process your personal data entered in this form for the purposes described in DSM's Privacy Policy. Plans for the merger were announced in November last year, but the deal only completed yesterday. 02 Jul 2018 --- Royal DSM has announced the proposed sale of DSM Sinochem Pharmaceuticals (DSP) – a pharmaceutical joint venture with China’s Sinochem Group – to Bain Capital. DSM’s purpose is to create brighter lives for all. Original Data: European Inspections Database your Region. We use cookies to personalize content and ads, to provide social media features and to analyze our traffic.